We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
CEVA Inc
CEVA
$1.08B
| $714K | ﹤0.01% |
33,476
| – | – |
|
2077
Heritage Financial
HFWA
$1.22B
| $709K | ﹤0.01% |
41,721
+2,300
| +6% | +$37.6K |
|
|
HSII
2078
DELISTED
Heidrick & Struggles
HSII
| $708K | ﹤0.01% |
28,802
+525
| +2% | +$12.3K |
|
2079
First Financial Corp
THFF
$970M
| $708K | ﹤0.01% |
19,740
+900
| +5% | +$30.8K |
|
|
CKP
2080
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $707K | ﹤0.01% |
65,303
+1,900
| +3% | +$24.1K |
|
|
BBL
2081
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $706K | ﹤0.01% |
15,947
+437
| +3% | +$19.8K |
|
|
ONIT
2082
Onity Group
ONIT
$332M
| $703K | ﹤0.01% |
5,681
+139
| +3% | +$18.6K |
|
|
GBL
2083
DELISTED
GAMCO Investors, Inc.
GBL
| $703K | ﹤0.01% |
16,637
+2,275
| +16% | +$98.1K |
|
2084
National Grid
NGG
$81.6B
| $700K | ﹤0.01% |
11,228
-539
| -5% | -$35.5K |
|
2085
Veeva Systems
VEEV
$37.3B
| $700K | ﹤0.01% |
27,414
+1,190
| +5% | +$33.5K |
|
2086
FormFactor
FORM
$9.15B
| $699K | ﹤0.01% |
78,776
+2,900
| +4% | +$25.2K |
|
|
AMRI
2087
DELISTED
Albany Molecular Research Inc
AMRI
| $699K | ﹤0.01% |
39,708
+700
| +2% | +$11.9K |
|
2088
Spok Holdings
SPOK
$240M
| $698K | ﹤0.01% |
36,400
+1,700
| +5% | +$31.2K |
|
2089
BioCryst Pharmaceuticals
BCRX
$2.4B
| $696K | ﹤0.01% |
77,074
+7,990
| +12% | +$82.7K |
|
|
LHCG
2090
DELISTED
LHC Group LLC
LHCG
| $696K | ﹤0.01% |
21,059
+200
| +1% | +$6.24K |
|
2091
Autoliv
ALV
$9.04B
| $695K | ﹤0.01% |
8,189
-1,111
| -12% | -$88K |
|
|
SN
2092
DELISTED
Sanchez Energy Corporation
SN
| $694K | ﹤0.01% |
53,346
+3,560
| +7% | +$43.5K |
|
|
GTS
2093
DELISTED
Triple-S Management Corporation
GTS
| $693K | ﹤0.01% |
36,663
+1,787
| +5% | +$37.3K |
|
|
ELNK
2094
DELISTED
EarthLink Holdings Corp.
ELNK
| $691K | ﹤0.01% |
155,604
+7,800
| +5% | +$34.6K |
|
|
CZR
2095
DELISTED
Caesars Entertainment Corporation
CZR
| $689K | ﹤0.01% |
65,436
+3,700
| +6% | +$40.9K |
|
2096
AngioDynamics
ANGO
$649M
| $688K | ﹤0.01% |
38,652
+1,300
| +3% | +$24.2K |
|
2097
Usana Health Sciences
USNA
$283M
| $687K | ﹤0.01% |
12,362
+1,392
| +13% | +$71.3K |
|
|
ATSG
2098
DELISTED
Air Transport Services Group
ATSG
| $687K | ﹤0.01% |
74,462
+2,900
| +4% | +$25.3K |
|
2099
Accuray
ARAY
$34.6M
| $686K | ﹤0.01% |
73,796
+8,625
| +13% | +$68.7K |
|
2100
Gray Television
GTN
$557M
| $685K | ﹤0.01% |
49,543
+7,750
| +19% | +$88.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.